Black Diamond Therapeutics
Price & Volume
Stats
See more52W Range | $1.36-$7.66 |
Market Cap | $79.3M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.27 |
News
See moreYahoo Finance • 18 days ago
Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy
Yahoo Finance • last month
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Yahoo Finance • 2 months ago
NAYA Biosciences Announces Nomination of New Board Members
About
CEO | Dr. Mark A. Velleca M.D., Ph.D. |
Address | One Main Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 24 |
